Jubilant Pharmova informs about outcome of board meeting

29 May 2023 Evaluate
Pursuant to Provisions of Regulation 33 read with Regulation 30 and other applicable provisions of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Jubilant Pharmova has informed that the Board of Directors of the Company has, at its meeting held today, on Monday, May 29, 2023 considered and approved the Audited Standalone and Consolidated Financial Statement of the Company for the quarter and Financial Year ended March 31 2023.

The above information is a part of company’s filings submitted to BSE.

Jubilant Pharmova Share Price

878.05 -22.90 (-2.54%)
24-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1730.55
Dr. Reddys Lab 1299.40
Cipla 1326.30
Zydus Lifesciences 904.35
Lupin 2251.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×